CCRL2 and neoplasm: CCRL2 upregulation confers a migratory advantage for the epidermal SCC tumor cells, particularly at the invasive front of the epidermis-dermis junction, facilitating their migration towards the dermis, where a gradient of its high-affinity ligand, Chemerin, is established by senescent fibroblasts [320].